Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subconjunctival dexamethasone in uncomplicated cataract surgery
ACTRN12613000314729Phase 4Not yet recruiting
- Sponsor
- Alfred Health
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexamethasone in cataract (2 arms), sponsored by Alfred Health. Primary endpoints: Post-operative ocular inflammation and Macular oedema. Planned start Apr 2013; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
cataract
Beyond the preview
Go deeper on ACTRN12613000314729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000314729.